United States securities and exchange commission logo June 18, 2020 Antony Koblish President and Chief Executive Officer TELA Bio, Inc. 1 Great Valley Parkway, Suite 24 Malvern, Pennsylvania 19355 Re: TELA Bio, Inc. Draft Registration Statement on Form S-1 Submitted June 15, 2020 CIK No. 0001561921 Dear Mr. Koblish: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason L. Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rachael Bushey